中文 | English
Return
Total: 564 , 1/57
Show Home Prev Next End page: GO
Author:( Xing-wei, WU)

1. Bioequivalence and pharmacokinetic study of glipizide by HPLC-MS/MS

Xing-Wei WU

Chinese Pharmaceutical Journal 2013;48(14):1204-1208

2.Daily Intake of Boron through Food and Drinking Water for People Living in Different Environments

Xiaoru XING ; Guoping WU ; Fusheng WEI

Journal of Environment and Health 1993;0(03):-

3.Determination of BIS50 and ED50 for propofol during induction by sequential experimental method

Xing XU ; Xiulan WEI ; Xinmin WU

Chinese Journal of Anesthesiology 2001;21(1):7-9

4.Roles of B-cell receptor signaling and its targeted inhibitors in lymphoid malignancies

Xing DAI ; Xiaoyi JIA ; Yujing WU ; Wei WEI

Chinese Pharmacological Bulletin 2014;(5):604-607

5.Clinical analysis of surgical treatment of 79 patients with primary cardiac tumors

Wei TAN ; Chaoguang WU ; Hong ZHANG ; Jie XING

Cancer Research and Clinic 2013;(3):193-194

6.Pharmacokinetics of Berberine in Puerariae and Scutellariae and Coptidis Decoction in Vivo of Dog

Yanping WU ; Xiaomei TAN ; Xuefeng XING ; Wei ZHANG

China Pharmacy 2001;0(11):-

9.Primary surgical repair of tetralogy of Fallot in symptomatic neonates and premature infants

Quansheng XING ; Qin WU ; Wei LIU ; Yueyi REN ; Qian CAO

Chinese Journal of Thoracic and Cardiovascular Surgery 2017;33(5):262-266

10.Meta-analysis of regimen SOX versus XELOX in treatment of Chinese patients with advanced gastric carcinoma

Yuanjun LI ; Juan XING ; Hanchang WU ; Xu WEI ; Hongmei ZHANG

Chinese Journal of Biochemical Pharmaceutics 2015;37(5):56-60

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 564 , 1/57 Show Home Prev Next End page: GO